OSTEOPENIA AND OSTEOPOROSIS TREATMENT INNOVATION
A new way of thinking about an age-old problem
At Bone Health Technologies, we develop breakthrough solutions to help people defend against osteoporosis and osteopenia. Our mission is simple: to empower people to lead longer, stronger, and more active lives by safeguarding bone density from the effects of menopause, aging, cancer, and other degenerative causes of bone loss.
Our first holistic bone health solution, Osteoboost, is FDA-cleared to treat osteopenia in postemenopausal women and first devices are expected to ship in late 2024.
This journey is just beginning, and we’re happy you’re here.
Our customers
FOR PATIENTS AND CAREGIVERS
We offer innovative, holistic solutions to slow the loss of bone density and strength, and keep you active and healthy longer.
FOR MEDICAL PROFESSIONALS
We provide a safe and convenient non-drug therapy, plus an actionable platform for tracking patient progress in tandem with your routine DEXA scanning.
Who prescribes Osteoboost? Primary care and internal medicine doctors, endocrinologists, OB/GYN professionals, rheumatologists, nephrologists, gerontologists, oncologists, physical therapists, and more.
FOR HEALTH SYSTEMS
We deliver an affordable way to significantly reduce the cost of bone fractures while affording patients a higher quality of life.
Leadership
Laura Yecies
Chief Executive Officer, President
Serial entrepreneur, formerly CEO at SyncThink, Catch (acq. Apple), and SugarSync (acq. J2). Led successful brands at Check Point, Netscape, Yahoo. MBA from Harvard, MSFS Georgetown.
Michael Jaasma
Co-founder, Chief Scientific Officer
Co-founder of BHT, 20 years as a technical lead in medical device development. PhD in orthopedic biomechanics from UC Berkeley. Former Reviewer and Branch Chief at the FDA in CDRH.
Pamela Peeke, MD
Chief Medical Officer
Expert in women’s health, menopause, and longevity, member of the National Menopause Foundation Medical Advisory Board and a Trustee on the American College of Sports Medicine Board.
Derek Hillstrom
VP Engineering
20 years of medical device development and manufacturing at St Jude Medical, Autonomic Technologies and Niveus Medical. University of Missouri, Aerospace, Aeronautical and Astronautical Engineering
Gabriel Griego
Marketing
Seasoned sales, marketing, and revenue/commercialization leader. Track-record of successfully designing and executing go-to-market for consumer/medical products. Led marketing for PowerBar, Game Ready, and AlterG.
Daniel Beeler
Vice President, Operations
Operational leader at scale, highly experienced with technical, regulatory, clinical, and commercial medical device development. Former CEO at Cardiospire and CTO at SyncThink and Metascrape.
Priya Patel
Chief Product Officer
Entrepreneur and product leader. Founder and CEO of Wellen (acq. by BHT), a science-based osteoporosis exercise platform. Former Head of Product at Sesame. A.B. from Harvard, J.D. from Columbia.
Dave McGurl
Regulatory
Director of Regulatory Affairs at MCRA and expert in orthopedics and medical devices. worked for 7 years at the FDA in the premarket orthopedic devices as acting branch chief and senior premarket lead reviewer.
Board of Directors
Laura Yecies
President and Chief Executive Officer at Bone Health Technologies
Shane Mangrum, MD
Co-founder and co-inventor, Bone Health Technologies, PM&R physician at Polaris Spine
Eric Meyer
Independent Board Member and strategic advisor at Bone Health Technologies
Jeani Delagardelle
Co-founder and former Managing Director of New Leaf Venture Partners
Ella Seitz
Partner at Esplanade Ventures. Leader in driving growth, digitization and new business models in healthcare.
Sam Goldberger, MD
Co-Founder and Managing Partner of Ambit Health Ventures. Ophthalmologist and ophthalmic surgeon.
Eran Steinberg
Serial Entrepreneur with 5 successful exits.
Early stage investor and board member, >300 granted patents,
MSc. Imaging Science, MS Regulatory Science
John Osborne
Managing Partner, Good Growth Capital. Co-founded and Director of The Harbor Entrepreneur Center. (Board observer)
Our investors
Special thanks to our incredible investors who believe in Osteoboost and want to make the world a better, stronger, and healthier place for everyone.
Recent announcements
Bone Health Technologies Acquires Wellen
Bone Health Technologies takes a pivotal step toward a future of comprehensive one-stop bone health care for patients everywhere REDWOOD CITY, Calif. (July 25, 2024) – Bone Health Technologies (BHT), a leading medical technology innovator developing breakthrough non-pharmacological solutions to improve bone health and reduce fractures, today announced the company[…]
Read moreBone Health Technologies Granted Fifth U.S. Patent for Low Bone Density Treatment Osteoboost, Adds Two Key Executives
REDWOOD CITY, CA (July 2, 2024) – Bone Health Technologies (BHT), a leading medtech innovator developing breakthrough noninvasive and drug-free solutions for low bone density, today announced the company has been awarded a fifth patent for Osteoboost—the first and only FDA-cleared prescription medical device to treat osteopenia. The patent, US[…]
Read moreBone Health Technologies Secures $5 Million in Funding to Transform Osteopenia Care
BHT closes oversubscribed financing round, adds new investors to revolutionize low bone density treatments Redwood City, CA – March 4, 2024 – Bone Health Technologies (BHT), a health technology innovator developing breakthrough non-invasive solutions for bone health, today announced the company has raised a new $5 million funding round from[…]
Read moreContact us
OsteoBoost is not yet available for sale. Please sign up below if you would like to be notified when the product is available for preorders.